https://pandefense.com/homepage daily 0.75 2020-04-15 https://pandefense.com/team daily 0.75 2026-01-17 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1587673150012-IX4XPPVC5YRFJ5L1295T/Larry%2BBrilliant.jpg Team Larry Brilliant, MD, MPH Founder and CEO of Pandefense Advisory, epidemiologist, philanthropist Expertise: Epidemiology, public health, infectious diseases, public policy, philanthropy View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616670661127-IKQ5UTJ183ALW9NN2A0Y/W%C3%A4ndi+Bruine+de+Bruin.jpg Team Wändi Bruine de Bruin, PhD Professor of public policy, psychology and behavioral science, University of Southern California Expertise: Behavioral and decision science, public health, public policy, communications View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1617641419108-P7KJQJ8HOBA828IINMLG/Kirstin+Chickering+-+Pandefense.JPG Team Kirstin Chickering, MPH Department of Epidemiology, UCLA Fielding School of Public Health Expertise: Global health, health education, public health program planning, implementation and evaluation View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616670984868-K8IBK8MGWCA3BW2DWDKU/Dr.+Lisa+E.+Danzig+-+Photo.JPG Team - Lisa E. Danzig, MD Lisa E. Danzig, MD Infectious disease specialist in San Francisco, California developing vaccines, diagnostics, and drugs. Expertise: Infectious disease specialist dealing with a broad array of emerging infectious diseases, including respiratory and blood-borne pathogens. View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671951043-FFN77UBJ5J81775YOWU7/Baruch+Fischhoff%2C+PhD.png Team Baruch Fischhoff, PhD Professor of engineering and public policy, Carnegie Mellon University Expertise: Public health, data science, behavioral and decision science, public policy, communications, risk analysis View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671024099-KGLQNJH7GJM4G9350OIN/VG+Photo.png Team - Veronica Garcia Veronica Garcia Executive Assistant to Dr. Larry Brilliant, Pandefense Advisory Expertise: Administration, philanthropy View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616672459447-XVF0ZKNFT543Y8K1VCJA/Laurie+Garrett.jpg Team Laurie Garrett Columnist and author of award-winning books on public health, including The Coming Plague Expertise: Epidemiology, public health, infectious diseases, public policy, communications View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671418102-U7DOYRBGBT5B82V0S7MQ/Lee-Gunn-head-shot-photo.jpg Team Lee Gunn (In Memoriam) Vice Admiral, U.S. Navy (Retired) Expertise: National security, public policy, military and defense View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616763647201-45SQCGALAYFHPBQZSC4U/Scott-P.-Layne-MD-FACP-FIDSA-%25E2%2580%2594.jpg Team Scott P. Layne, MD, FACP, FIDSA Physician and professor emeritus of public health, UCLA Expertise: Epidemiology, public health, infectious diseases, virology, diagnostics, national security View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671395120-ERNTPBH16BVERGASZLGS/W.+Ian+Lipkin%2C+MD.jpg Team W. Ian Lipkin, MD Professor of Epidemiology, Columbia University Expertise: Epidemiology, public health, infectious diseases, virology, diagnostics, national security View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/faaa1702-2dc2-4d98-baad-5c7a67b0f46c/Amy_Lockwood_Headshot_21G8732_Web.jpg Team - Make it stand out Amy Lockwood MS, MBA, PhD Senior Advisor, HIV Cure Africa Acceleration Partnership (HCAAP) Expertise: Global health, public policy, strategy, operations, communications, program evaluation View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1623781742199-FL2FSHWOZM8EKD0N1D6C/Agastya+Mondal.jpg Team - Make it stand out Agastya Mondal Ph.D. Student, University of California, Berkeley Expertise: Epidemiology, software engineering, data science View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671570929-M1XHT0T1N639DD2BN266/Karen+Pak+Oppenheimer.jpg Team - Karen Pak Oppenheimer Strategy and operations adviser for philanthropic, social enterprise, and nonprofit organizations Karen Pak Oppenheimer, MS, MPH Principal, Pandefense Advisory Expertise: Global health, strategy and operations, social ventures, philanthropy View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671620037-NG34ZO9A9WYAWOO1ELAC/Arthur+Reingold%2C+MD.jpg Team Arthur Reingold, MD Professor of Epidemiology, University of California, Berkeley Expertise: Epidemiology, public health, infectious diseases, diagnostics, public policy View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671644071-ZYHK3V2C5CUOE2QOK5BP/Anne+W.+Rimoin%2C+PhD.jpg Team Anne W. Rimoin, PhD Professor of epidemiology, UCLA schools of public health and medicine Expertise: Epidemiology, public health, infectious diseases, virology View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1587674356482-C5G3NOM3Z2FVRAGU15QA/Samuel%2BV.%2BScarpino.jpg Team Samuel V. Scarpino, PhD Managing Director for Pathogen Surveillance, Rockefeller Foundation Expertise: Epidemiology, public health, data science, behavioral and decision science View Profile → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671787926-MQRNA52GJZXK2QYS77X6/Jeffrey+Shaman+Photo+-+2021.jpeg Team Jeffrey Shaman, PhD Professor in the Department of Environmental Health Sciences and Director of the Climate and Health Program at the Columbia University Mailman School of Public Health Expertise: Climate, environmental health, public health View Profile → https://pandefense.com/home daily 1.0 2021-05-07 https://pandefense.com/services daily 0.75 2022-01-11 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588128482367-NE895QPCH0II382PO1CJ/Pandefense+Icons+Left+Justified-05-05-08.png Services https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588128497960-WEKAYRODJ2J70TCR5VS0/Pandefense+Icons+Left+Justified-07.png Services https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588128445994-T9H04Z2CSGXIVPUWR7HS/Pandefense+Icons+Left+Justified-05-05-05.png Services https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588128468869-1EJO1S595O4ZNJWX9PBD/Pandefense+Icons+Left+Justified-05-05-06.png Services https://pandefense.com/contact daily 0.75 2020-04-30 https://pandefense.com/resources daily 0.75 2020-06-05 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588275955087-N3KQHEYJV19H2N6NS0AW/F1.large.jpg Resources - SCIENCE | March 25, 2020 The effect of human mobility and control measures on the COVID-19 epidemic in China Samuel V. Scarpino Read More → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1591377625694-24V67267FR5UOUZ9LRC0/jama-logo-img.jpg Resources - JAMA | June 4, 2020 Viewpoint: Making Decisions in a COVID-19 World Baruch Fischhoff Read More → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588275733070-LG6VT9UIHHK8UOCFOGN7/Screen%2BShot%2B2020-04-30%2Bat%2B1.17.01%2BPM.jpg Resources - NATURE MEDICINE | March 17, 2020 The proximal origin of SARS-CoV-2 W. Ian Lipkin Read More → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588276005402-NFWXJCZVYIVFY08SH8JF/online-marketing-hIgeoQjS_iE-unsplash.jpg Resources - SCIENCE TRANSLATIONAL MEDICINE | March 11, 2020 New coronavirus outbreak: Framing questions for pandemic prevention Scott P. Layne Read More → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588276069914-EB7SLVN1TIDY4D9Q3X3D/Screen%2BShot%2B2020-04-28%2Bat%2B9.38.51%2BPM.jpg Resources - UCLA HEALTH | April 12, 2020 UCLA HSW/LAC FR COVID-19 Risk Assessment Anne Rimoin Read More → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588276104330-ZH6KTDD5CNXHUE5NJ42N/corona.jpg Resources - UNIVERSITY OF SOUTHERN CALIFORNIA | April, 2020 Understanding America Study, Coronavirus in America (COVID) Survey Wändi Bruine de Bruin Read More → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588277233716-9ZIH8OB9D0YKABSLVDFC/science-in-hd-OdEB1LNUidc-unsplash.jpg Resources - MED RX IV | April, 2020 Incidence, clinical outcomes, and transmission dynamics of hospitalized 2019 coronavirus disease among 9,596,321 individuals residing in California and Washington, United States: a prospective cohort study Arthur L. Reingold Read More → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588009884062-Y9N906NDP60UGTVA9GM2/Larry%2BBrilliant.jpg Resources Larry Brilliant, MD, MPH Twitter → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588009913222-C9109MCQCX0AXOQ2SIB2/Garrett.jpg Resources Laurie Garrett Twitter → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588009929663-B1FQFPPRQTK6NLVJ9D7I/Anne%2BRimoin.jpg Resources Anne W. Rimoin, PhD, MPH Twitter → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588009955209-3T8N1EPGBMAIXXT0YA4H/Samuel%2BV.%2BScarpino.jpg Resources Samuel V. Scarpino, PhD Twitter → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588010777580-1EG6UFLIGKQMTNS6OEBC/jhu_covid_19_generic.png Resources JOHN HOPKINS UNIVERSITY & MEDICINE | 2020 Coronavirus Resource Center More Information → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588010722228-FR05ZIOF1MRW9WNKWU8M/nam-logo1.jpg Resources NATIONAL ACADEMY OF MEDICINE | 2020 Coronavirus Disease 2019 (COVID-19) News and Resources More Information → https://pandefense.com/privacypolicy daily 0.75 2020-05-02 https://pandefense.com/scott-z-burns daily 0.75 2020-05-01 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1587676459350-8U6WTQF7EQWLKAQRFDQ8/Scott.+Z+Burns.png Scott Z. Burns https://pandefense.com/samuel-v-scarpino daily 0.75 2021-07-15 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1587677643601-B3C5445BDJ1TM5S8MQDV/Samuel+V.+Scarpino.png Samuel V. Scarpino, PhD - Samuel V. Scarpino, PhD Managing Director for Pathogen Surveillance, Rockefeller Foundation Dr. Samuel Scarpino joined Pandefense Advisory at its founding in March 2020 when he was Assistant Professor at the Network Science Institute of Northeastern University. He left in July 2021 to become Managing Director for Pathogen Surveillance at the Rockefeller Institute. Dr. Samuel Scarpino is an expert in complex systems and network science, including forecasting and predictive modeling, complex network analysis, epidemiology, genomics and transcriptomics, social networks, and decision making under uncertainty. He is an assistant professor in the Network Science Institute at Northeastern University and has more than ten years of experience translating research into public health and clinical decision support tools. For his contributions to complex systems science, he was awarded the Junior Scientific Award by the Complex Systems Society. Outside academia, Dr. Scarpino is a member of multiple World Economic Forum working groups, is a strategic advisor to technology startups and biotechnology companies, and serves on the scientific advisory board for BioFire Diagnostics’s Trend surveillance system. He has given over 100 keynotes and professional presentations at international conferences, has published over 30 peer-reviewed articles, and is a deputy editor at PLoS Neglected Tropical Diseases. Dr. Scarpino earned a PhD from The University of Texas at Austin and was a Santa Fe Institute Omidyar Fellow. Expertise: Epidemiology, public health, data science, behavioral and decision science https://pandefense.com/lee-gunn-us daily 0.75 2021-03-26 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671418102-U7DOYRBGBT5B82V0S7MQ/Lee-Gunn-head-shot-photo.jpg Lee Gunn, U.S. - Lee Gunn, U.S. Vice Admiral, U.S. Navy (Retired) Admiral Lee Gunn is a retired U.S. Navy vice admiral with experience in planning for and responding to a variety of national security threats. He served 35 years in uniform, much of it at sea in surface warships and commanded a frigate, a squadron of destroyers, and the Third Fleet Amphibious Force. He also commanded the Navy Personnel Command and was the Department of the Navy Inspector General, serving both the Navy and Marine Corps prior to his retirement. Admiral Gunn then led the Institute for Public Research at CNA for 14 years, initiating scientific and policy research for federal, state and local governments across the fields of health, education, air traffic management, homeland security and justice, and the climate, energy, water and national security. Admiral Gunn now studies and speaks on the U.S. national security implications of climate change, energy usage and water scarcity. He is also a member of the U.S. Global Leadership Council and remains a founding director and executive committee member of the centrist American Security Project, a non-partisan, non-profit policy think tank. Admiral Gunn has a BA in psychology from UCLA and an MS in operations research from the Naval Postgraduate School. Expertise: National security, public policy https://pandefense.com/arthur-reingold daily 0.75 2021-03-26 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671620037-NG34ZO9A9WYAWOO1ELAC/Arthur+Reingold%2C+MD.jpg Arthur Reingold, MD - Arthur Reingold, MD Professor of Epidemiology, University of California, Berkeley Dr. Arthur Reingold focuses on the prevention and control of infectious diseases, including vaccine-preventable diseases and respiratory tract infections, such as influenza, in the U.S. and globally. He is a professor of epidemiology and head of the Division of Epidemiology and Biostatistics at the School of Public Health, University of California, Berkeley. Prior to joining the faculty there in 1987, he worked for the U.S. Centers for Disease Control for eight years. He has directed the CDC-funded California Emerging Infections Program since its inception in 1994. Dr. Reingold has also served on diverse advisory committees, including the Advisory Committee on Immunization Practices (ACIP) and WHO’s SAGE committee, and as president of both the Society for Epidemiological Research and the American Epidemiological Society. Among other honors, he was elected to membership in the Institute of Medicine (now the National Academy of Medicine) in 2003. He earned his AB and MD at the University of Chicago. Expertise: Epidemiology, public health, virology and infectious diseases, diagnostics, public policy https://pandefense.com/larry-brilliant daily 0.75 2023-11-10 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588009856542-XVDYKAQNMS5CVXVWZEAS/Larry+Brilliant.png Larry Brilliant, MD, MPH - Larry Brilliant, MD, MPH, FACPM Founder and CEO of Pandefense Advisory, epidemiologist, philanthropist Dr. Larry Brilliant is a physician and epidemiologist, CEO of Pandefense Advisory, senior counselor at the Skoll Foundation and a CNN Medical Analyst. Previously, he served on the board of the Skoll Foundation, was Chair of the Advisory Board of the NGO Ending Pandemics, the president and CEO of the Skoll Global Threats Fund, vice president of Google, and the founding executive director of Google.org. He co-founded the Seva Foundation, an NGO whose programs have given back sight to more than 5 million blind people in two dozen countries. In addition, he co-founded The Well, a progenitor of today's social media platforms. Earlier in his career, Dr. Brilliant was an associate professor of epidemiology and international health planning at the University of Michigan. Dr. Brilliant lived in India for nearly a decade where he was a key member of the successful WHO Smallpox Eradication Programme for SE Asia as well as the WHO Polio Eradication Programme. He was the founding chairman of the National Biosurveillance Advisory Subcommittee (NBAS), which was created by presidential directive of President George W. Bush, he was a member of the World Economic Forum's Agenda Council on Catastrophic Risk, and a "First Responder" for CDC's bio-terrorism response effort. Recent awards include the TED Prize, Time magazine's 100 Most Influential People, "International Public Health Hero," and four honorary doctorates. He has lectured at Oxford, Harvard, Berkeley and many other colleges, spoken at the Royal Society, the Pentagon, NIH, the United Nations, and some of the largest companies and nonprofits all over the world. He has written for Forbes, the Wall Street Journal, the Guardian, and other magazines and peer reviewed journals and was part of the Global Business Network where he learned scenario planning. Dr. Brilliant is the author of “Sometimes Brilliant,” a memoir about working to eradicate smallpox, and a guide to managing vaccination programs entitled “The Management of Smallpox Eradication.” Expertise: Epidemiology, public health, virology and infectious diseases, diagnostics, public policy, national security, philanthropy https://pandefense.com/w-ian-lipkin daily 0.75 2021-03-26 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671395120-ERNTPBH16BVERGASZLGS/W.+Ian+Lipkin%2C+MD.jpg W. Ian Lipkin, MD - W. Ian Lipkin, MD Professor of Epidemiology, Columbia University Dr. Ian Lipkin is internationally recognized for his contributions to global public health by developing innovative methods for infectious diseases diagnosis, surveillance, and discovery. He is the John Snow Professor of Epidemiology at the Mailman School of Public Health at Columbia University, where he also directs the Center for Solutions for ME/CFS, the Center for Research in Diagnostics and Discovery, and the Center of Infection and Immunity. Dr. Lipkin was the first to use subtractive cloning in microbial discovery and next-generation sequencing for investigating outbreaks. He also developed gene capture technologies including VirCapSeq-VERT and BacCapSeq as well as multiplexed serological assays to detect vector-borne diseases. These advances have been critical in replacing culture-dependent methods of global health management by creating new criteria for disease causation and de-linking spurious associations between putative agents and diseases, such as the MMR vaccine and autism. Dr. Lipkin has also been at the forefront of outbreak response to many of the world’s recent outbreaks, including West Nile Virus in NYC (1999), SARS in China (2003), MERS in Saudi Arabia (2012-16), Zika in the US (2016), encephalitis in India (2017), and COVID-19 (2020). He promotes public health awareness via print and broadcast media and served as the scientific advisor for the Soderbergh film “Contagion.” His prestigious honors include Pew Scholar (Biomedical Sciences), Walter Reed Distinguished Lecturer, the Drexel Prize in Translational Medicine, and the Technology Cooperation Award of the People’s Republic of China. He earned his MD at Rush. Expertise: Epidemiology, public health, virology and infectious diseases, diagnostics, data public policy https://pandefense.com/wandi-bruine-de-bruin daily 0.75 2021-03-26 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616670661127-IKQ5UTJ183ALW9NN2A0Y/W%C3%A4ndi+Bruine+de+Bruin.jpg Wändi Bruine de Bruin, PhD - Wändi Bruine de Bruin, PhD Professor of Public Policy, Psychology and Behavioral Science, University of Southern California Dr. Wändi Bruine de Bruin is a psychologist whose research aims to understand risk perceptions, decision making, and interventions. She is Provost Professor of Public Policy, Psychology, and Behavioral Science at the University of Southern California, where she holds positions in the public policy school, the psychology department and the centers for economics and health policy and for economics and social research. Her own research aims to understand and inform on how people make decisions about personal health, household finance, and well-being. To this end, she has designed survey modules for national survey panels such as USC’s Understanding America Study, including on public risk perceptions of coronavirus. Wändi also uses insights from psychology and behavioral science to develop and test interventions for promoting better decision outcomes and well-being. She has published over 100 papers on these topics across journals in psychology, policy, public health, and other fields and serves on the editorial boards of multiple publications including the Journal of Experimental Psychology: Applied, the Journal of Risk Research, and the Journal of Behavioral Decision Making. She has shared her expertise on panels on science communication at the National Academy of Sciences, on health communications at the Council of the Canadian Academies, and on pandemic influenza at the Seva Foundation. She received her PhD in behavioral decision research and psychology from Carnegie Mellon University. Expertise: Behavioral and decision science, public health, public policy, communications https://pandefense.com/baruch-fischhoff daily 0.75 2021-03-26 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616761418259-5EA31161O1BM4SZCSZV9/Baruch%2BFischhoff%252C%2BPhD.jpg Baruch Fischhoff, PhD - Baruch Fischhoff, PhD Professor of Engineering and Public Policy, Carnegie Mellon University Dr. Baruch Fischhoff is a world-renowned expert on decision and risk analysis. He is Howard Heinz University Professor in the Department of Engineering and Public Policy and the Institute for Politics and Strategy at Carnegie Mellon University. Dr. Fischhof is an elected member of the National Academy of Sciences and National Academy of Medicine and currently serves on its COVID-19 committee. He has chaired the Food and Drug Administration Risk Communication Advisory Committee and been a member of the Eugene (Oregon) Commission on the Rights of Women, the Department of Homeland Security Science and Technology Advisory Committee and the Environmental Protection Agency Scientific Advisory Board, where he chaired the Homeland Security Advisory Committee. He is past president of the Society for Judgment and Decision Making and the Society for Risk Analysis and has received awards for his intellectual contributions and teaching excellence. Dr. Fischhof’s 13 books include Acceptable Risk, Risk: A Very Short Introduction, and Counting Civilian Casualties. He is a graduate of the Detroit Public Schools, Wayne State University (BS, mathematics, psychology), and the Hebrew University of Jerusalem (PhD, psychology). Expertise: Public health, data science, behavioral and decision science, public policy, communications https://pandefense.com/laurie-garrett daily 0.75 2021-03-26 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616672459447-XVF0ZKNFT543Y8K1VCJA/Laurie+Garrett.jpg Laurie Garrett - Laurie Garrett Columnist and author of award-winning books on public health, including The Coming Plague Laurie Garrett is an author, speaker and columnist focused on emerging diseases, epidemics, pandemics, drug resistance, bioterrorism, and climate change. She is the only writer ever to have been awarded all three of the Big "Ps" of journalism: the Peabody, the Polk, and the Pulitzer, Ms. Garrett is a featured columnist for Foreign Policy magazine, a frequent contributing writer for The Lancet (among many other outlets), a Science Contributor for MSNBC, and the founder of the Anthropos Initiative, which engages at the nexus of the Anthropocene, climate change and human health. From 2004-2016, she was senior fellow for global health at the Council on Foreign Relations; she also served as a science advisor on the film “Contagion.” Ms. Garrett’s bestselling books include: The Coming Plague: Newly Emerging Diseases in a World Out of Balance (1994; adapted into a CNN documentary), Betrayal of Trust: The Collapse of Global Public Health (2002) and I Heard the Sirens Scream: How Americans Responded to the 9/11 and Anthrax Attacks (2011). Ms. Garrett earned an BS in biology from the University of California, Santa Cruz, attended graduate school in the Department of Bacteriology and Immunology at University of California, Berkeley and did immunology research in the Herzenberg Lab of Stanford University. She was a Fellow at the Harvard School of Public Health, named “Alum of the Year” by the University of California, Santa Cruz, and “Alum of the Decade” by the University of California Board of Regents. Expertise: Epidemiology, public health, virology and infectious diseases, public policy, communications, media and design https://pandefense.com/anne-w-rimoin daily 0.75 2021-03-26 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671644071-ZYHK3V2C5CUOE2QOK5BP/Anne+W.+Rimoin%2C+PhD.jpg Anne W. Rimoin, PhD - Anne W. Rimoin, PhD Professor of Epidemiology, UCLA Schools of Public Health and Medicine Dr. Anne Rimoin is an internationally recognized expert on emerging infections, global health, surveillance systems, and vaccination. She is a professor of epidemiology at the UCLA Fielding School of Public Health and Infectious Disease Division of the Geffen School of Medicine. Her pioneering research in emerging diseases includes the identification of new pathogens in humans and studying Ebola, especially in the Democratic Republic of Congo. Dr. Rimoin has been a strong advocate for capacity building in low resource settings and conducting disease surveillance in complex emergencies; she is currently leading a study of asymptomatic COVID-19 infection in Los Angeles health workforce and first responders. Dr. Rimoin has published more than 70 research articles featured in The New York Times, The Wall Street Journal, Nature, and Science. She appears frequently on television and radio discussing major issues surrounding disease emergence and has recently been a leading voice on the COVID-19 pandemic in national news for CNN and MSNBC. Dr. Rimoin earned her BA at Middlebury College, MPH at UCLA, and PhD at Johns Hopkins University. Expertise: Epidemiology, public health, virology and infectious diseases https://pandefense.com/lscott-p-layne daily 0.75 2021-03-26 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616763647201-45SQCGALAYFHPBQZSC4U/Scott-P.-Layne-MD-FACP-FIDSA-%25E2%2580%2594.jpg Scott P. Layne, MD, FACP, FIDSA - Scott P. Layne, MD, FACP, FIDSA Physician and Professor Emeritus of Public Health, UCLA Dr. Scott Layne is a physician-scientist known for cross-disciplinary work in epidemiologic modeling, applied virology, large-scale laboratory technology and biological security policy. He is professor emeritus at the UCLA School of Public Health and a prior staff member at the Los Alamos and Lawrence Livermore National Laboratories. With UCLA and LANL, Dr. Layne designed an automated high-throughput laboratory for analyzing numerous infectious disease samples to enable worldwide situational awareness of outbreaks and pandemics. In addition, he was principal investigator of the NIAID/NIH Center of Excellence for Rapid Influenza Surveillance and Response, which conducted studies on threatening influenza viruses. From 2008 to 2010, he served as a member of the National Biosurveillance Advisory Subcommittee, authorized by presidential directive 21. Dr. Layne has over 50 publications that have appeared in such journals as PNAS, Nature and Science, as well as two books and six patents. He is an editor of Firepower in the Lab (National Academy Press, 2001) and Jane's Chem-Bio Handbook (2nd and 3rd editions). He is Board Certified in Internal Medicine and Infectious Diseases and practices in Los Angeles, California. After earning his MD at Case Western Reserve University, he studied applied physics at Stanford. Expertise: Epidemiology, public health, virology and infectious diseases, diagnostics https://pandefense.com/news daily 0.75 2023-12-01 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/dfa88116-b661-4faa-a05e-8d178292d44d/220103204037-amanpour-brilliant-alakija-omicron-exlarge-169+%281%29.jpg News - Pandemic at a 'Crossroads,' Warn Scientists CNN | Larry Brilliant & Dr. Ayoade Alakija | January 2022 Epidemiologist Dr. Larry Brilliant and co-chair of the African Union's African Vaccine Delivery Alliance Dr. Ayoade Alakija tell Amanpour the pandemic "isn't over" amid Omicron and staggering vaccine inequality. Read More → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/825a00cd-eef9-4fef-91e7-577a7cb511f1/Marketplace+Morning+Report+Podcast+-+What+needs+to+be+done+after+COVID+vaccine+boosters.png News - What Needs to be Done After COVID Vaccine Boosters? by Marketplace Interview by David Brancaccio | October 28, 2021 COVID-19 vaccine boosters are slowly but methodically becoming another part of the U.S. pandemic response. The Centers for Disease Control recently approved use for people aged 65 and older and for immunocompromised adults. Listen Here → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1618920487984-EX2YI4XYJ763HRW8LZIV/image.jpg News - Ask An Expert: Dr. Larry Brilliant by KCBS 106.7 | April 16, 2021 We've all been living in a pandemic for over a year now, and a lot has changed. For more on what might come next, KCBS Radio's Stan Bunger spoke with Dr. Larry Brilliant, physician, epidemiologist, and CEO of Pandefense Advisory. Listen Here → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616757876730-152HA72LUJP2Y4PCSPAA/Brilliant.Kornfield.web_.jpg News - Mindfulness and Medicine: Jack Kornfield and Larry Brilliant By City Arts and Lectures | March 23, 2021 Watch Video → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616758338122-6ZQTDE2I532U9K2ZTOQC/maxresdefault.jpg News - What's Next for COVID-19? By Grace Cathedral SF | March 1, 2021 A Conversation between Dr. Larry Brilliant and the Rev. Dr. Malcolm Clemens Young, Dean of Grace Cathedral Watch Video → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1618921303362-17ZBDO4FKM1XH9LR3665/Instagram+Live+with+Seth+MacFarlane+and+Larry+Brilliant.jpg News - Instagram Live with Seth MacFarlane and Larry Brilliant By The Science and Entertainment Exchange | February 1, 2021 Watch Video → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1618924428103-0P3NIADPYCVGYOZLSZUZ/International+Politics+%26+Pandemic+Control.jpg News - International Politics & Pandemic Control By Literature Live! | August 14, 2020 Anil Dharker hosts a conversation between Triple Pulitzer Prize winner Thomas Friedman and Dr. Larry Brilliant Watch Video → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/e2ff67a2-b7d9-43fe-9b64-adcf6464ce87/image-asset.jpg News - What No One Knows About COVID-19, with Larry Brilliant In the Bubble with Andy Slavitt | July 2020 Listen Here → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616771612227-63Y0PJUDFNNARCC91P2F/200616-ASNC-Superpower+Interrupted-THUMB2.jpg News - Dr. Larry Brilliant and the Venerable Tenzin Priyadarshi The Asia Society | June 26, 2020 Watch Video → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1618925761434-3PI95SIG9NMWZ0ZDCYML/Diving+into+the+Depths+and+Looking+Into+the+Future.png News - Diving into the Depths and Looking Into the Future with Rabbi Sydney Mintz By Reimagine | May 12, 2020 Very few people have been at the center of and contributed to, the end of a global pandemic. Dr. Brilliant is one of those few. Watch Video → https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616758614978-FDAZUG6IWDTQPMFTERDZ/maxresdefault%2B%25281%2529.jpg News - GZero World with Ian Bremmer April 30, 2020 How to Change the World: Dr. Larry Brilliant and Eradicating Smallpox Watch Video → https://pandefense.com/pandefense daily 0.75 2020-05-02 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588393987049-XFKO24K656T9N3OVGJHV/Pandefense-1.jpg Pandefense Image https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588393987047-I9NR8LPNBVWZ0TLL1G7F/Pandefense-2.jpg Pandefense Image https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588393986963-EBAPRBP6DK5CVPRTZ65H/Pandefense-3.jpg Pandefense Image https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1588393986067-N1858O3RPQRRPMVQZAO0/Pandefense-4.jpg Pandefense Image https://pandefense.com/veronica-garcia daily 0.75 2021-03-26 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671024099-KGLQNJH7GJM4G9350OIN/VG+Photo.png Veronica Garcia - Veronica Garcia Executive Assistant to Dr. Larry Brilliant, Pandefense Advisory Veronica Garcia is executive assistant to Dr. Larry Brilliant who she had worked with earlier when he was CEO of the Skoll Global Threats Fund. Prior to working with Dr. Larry at Skoll, she had over a decade of experience in the healthcare industry through her work with MPM Capital, one of the world's largest life science-dedicated venture capital firms. At MPM she assisted Dr. Gary Patou, a managing partner, in the startup of four biotech companies and the development of drugs for cancer, respiratory illnesses, and pain management, actively participating in the clinical, regulatory, and commercialization processes. Ms. Garcia spent the decade prior to that in various positions in advertising, marketing, and public relations. Concurrent to her work at Pandefense Advisory, she is helping develop a tennis and sports program as well as a scholarship program for Voice of the Free, a Philippine-based NGO working with survivors of human trafficking. Expertise: Administration, philanthropy https://pandefense.com/lisa-danzig daily 0.75 2021-03-26 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616670984868-K8IBK8MGWCA3BW2DWDKU/Dr.+Lisa+E.+Danzig+-+Photo.JPG Lisa Danzig - Lisa E. Danzig, MD Dr. Lisa E. Danzig is an infectious disease specialist in San Francisco, California. She has spent more than 20 years within the pharmaceutical industry (Chiron, Novartis, Grifols, PaxVax) developing vaccines, diagnostics, and drugs, and is currently advising companies and investors. Dr. Danzig studied biology at Reed College and medicine at OHSU. In San Francisco, she completed internal medicine residency training at CPMC, in Atlanta, served as an Epidemic Intelligence Service Officer with the US CDC, with a special focus on hospital acquired infections. Following CDC, she completed an Infectious Diseases fellowship in San Francisco, at the UCSF-Mt. Zion campus. She joined Chiron in 1997 and spent the following decade leading meningococcal vaccine development teams (Menjugate, Menveo, Bexsero). After Novartis acquired Chiron in 2006, she moved to Siena, Italy to lead early clinical development. With the Business Development group, she was responsible for clinical licensing evaluation, and led the R&D integration team for an acquisition in China (Tianyuan Biopharm, Hangzhou, CN). She returned to the US to lead the Medical and Scientific Affairs group for Novartis Diagnostics, a global market leader that provided blood screening solutions for nucleic acid detection of HIV, HBV, HCV, WNV and emerging threats (Dengue, Chikungunya, Zika, Babesia). After the acquisition of Novartis Diagnostics by Grifols, she joined PaxVax (first as a special advisor, and subsequently as EVP and Chief Medical Officer). PaxVax had a social mission to provide vaccines for diseases that were overlooked by the industry and yet of importance to travelers (e.g., Cholera, Typhoid). Emergent Biosolutions acquired PaxVax in October 2018. Dr. Danzig currently provides advisory services to investor groups (VC, PE, Philanthropists) and biotechnology companies. Serves as an independent director at OrSense (non-invasive hemoglobin monitoring system). In the non-profit world, serves on the advisory board of the Lemelson Foundation (improving lives through invention), as a director of the Karuna Foundation (adaptation/climate change) and Sustainable Sciences Institute (building global public health research capacity), and as VP on the board of the International Society of Travel Medicine Foundation (ISTMF). Specialty: Infectious disease specialist dealing with a broad array of emerging infectious diseases, including respiratory and blood-borne pathogens. Infectious Diseases and specialty training: Epidemic Intelligence Service Officer (EIS Officer) at the CDC and Infectious Diseases Fellowship at UCSF-Mount Zion. Medical School & Residency: Oregon Health & Science University School of Medicine, Portland, Oregon and California Pacific Medical Center, San Francisco, CA. https://pandefense.com/karen-pak-oppenheimer daily 0.75 2021-03-26 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671570929-M1XHT0T1N639DD2BN266/Karen+Pak+Oppenheimer.jpg Karen Pak Oppenheimer - Karen Pak Oppenheimer, MS, MPH Karen is a strategy and operations adviser for philanthropic, social enterprise and nonprofit organizations, currently focusing on climate action and the COVID-19 pandemic response. Most recently, she supported the San Francisco Department of Public Health’s contact tracing efforts as a strategy and operations consultant. Previously, she served as chief operating officer for Institute for Transformative Technologies, as vice president of World Health Partners, spending the last decade centered on bringing healthcare services to rural India and East Africa through technology innovations and market-based approaches. She also worked for the Lawrence Livermore National Laboratory, Oracle Corporation, the United Nations Population Fund (China), and start-up biotechnology companies. Karen serves as board chair of OASIS Sahel, director at Social Alpha Foundation, and a Regent at the Mercersburg Academy. She holds a bachelor of science in chemical engineering from Johns Hopkins University, a master of science in biotechnology from Northwestern University, and a master of public health from the University of California, Berkeley. Karen is a native of Hong Kong, speaks Cantonese, Mandarin and Spanish. https://pandefense.com/jeffrey-shaman daily 0.75 2021-03-26 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1616671787926-MQRNA52GJZXK2QYS77X6/Jeffrey+Shaman+Photo+-+2021.jpeg Jeffrey Shaman - Jeffrey Shaman Jeffrey Shaman is a Professor in the Department of Environmental Health Sciences and Director of the Climate and Health Program at the Columbia University Mailman School of Public Health. He studies the survival, transmission and ecology of infectious agents, including the effects of meteorological and hydrological conditions on these processes. Work-to-date has primarily focused on mosquito-borne and respiratory pathogens. He uses mathematical and statistical models to describe, understand, and forecast the transmission dynamics of these disease systems, and to investigate the broader effects of climate and weather on human health. Dr. Shaman holds a BA in biology from the University of Pennsylvania and an MA, MPhil, and PhD in climate and geophysics from Columbia. https://pandefense.com/kirstin-chickering daily 0.75 2021-04-05 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1617641419108-P7KJQJ8HOBA828IINMLG/Kirstin+Chickering+-+Pandefense.JPG Kirstin Chickering - Kirstin Chickering, MPH Department of Epidemiology, UCLA Fielding School of Public Health Kirstin is the Associate Director the UCLA-DRC Research Group at the UCLA Fielding School of Public Health. She manages ongoing international research studies on emerging infectious diseases, including Ebola, monkeypox, polio, sleeping sickness and other diseases. Prior to coming to UCLA, Kirstin worked at FHI360 for several years as well as at the Los Angeles County Health Department, STD Program. Since the Covid-19 pandemic began, Kirstin has worked with a number private clients to help them develop and implement back to work safety protocols. Her clients have included Beyond Meat, Legendary Entertainment, United Talent Agency, Gersh Agency, Topa Equities and several TV productions. Kirstin earned her B.A. in Political Science and French at Duke University and her M.P.H. at UCLA. She is fluent in French and also speaks some German and Spanish. Expertise: Global health, health education, public health program planning, implementation, and evaluation https://pandefense.com/agastya-mondal daily 0.75 2021-06-15 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/1623781504222-3ZUZBWXD81ZI1F425WTW/Agastya+Mondal.jpg Agastya Mondal - Agastya Mondal Ph.D. Student, University of California, Berkeley Agastya Mondal is a Ph.D. student at the University of California, Berkeley, where he studies epidemiology and computational biology. His doctoral research focuses on developing computational models of vector-borne infectious disease transmission. He also supports various projects in the global health policy space. Prior to joining Berkeley, Agastya worked as a software engineer and data scientist in the biotechnology and humanitarian aid sectors. He graduated from 2016 from Johns Hopkins University with a BS in Biomedical Engineering and Applied Mathematics. https://pandefense.com/amy-lockwood daily 0.75 2021-11-02 https://images.squarespace-cdn.com/content/v1/5e972a6c760cdc02748a919e/faaa1702-2dc2-4d98-baad-5c7a67b0f46c/Amy_Lockwood_Headshot_21G8732_Web.jpg Amy Lockwood - Amy Lockwood MS, MBA, PhD Senior Advisor, HIV Cure Africa Acceleration Partnership (HCAAP) Amy is a public health specialist with deep experience in strategy, management, and communications. She advises organizations sectors engaged in addressing global health challenges, including COVID-19, HIV, and nutrition. Amy has spent her career bridging the corporate, academic, and non-profit sectors to design and implement solutions to the world’s most difficult problems. Most recently, she has led efforts to improve access to testing as part of the COVID-19 pandemic response as the first Testing Branch Chief for the San Francisco Department of Health and the Director of Public Health for Color Health. She has also held leadership roles at the University of California, San Francisco, Stanford University, and the Clinton HIV/AIDS Initiative, providing strategic guidance and managing operations to advance research, design products, and implement programs to strengthen health systems. Amy received her PhD in Global Health Sciences at UCSF in 2019 with a research focus on the role of improved leadership and management in achieving better population health outcomes. Amy also holds an MBA from the Stanford Graduate School of Business, an MS in Marketing and a BS in Communications, both from Northwestern University. Prior to working in global health, Amy was a strategy consultant at Mercer Management Consulting (now Oliver Wyman) specializing in consumer market research, branding, and communication.